CCDC152: A Drug Target / Disease Biomarker (G100129792)

Target Name: CCDC152

NCBI ID: G100129792

CCDC152

Other Name(s): Coiled-coil domain-containing protein 152 | coiled-coil domain containing 152 | CH5400 | CC152_HUMAN | Coiled-coil domain containing 152

CCDC152: A Drug Target / Disease Biomarker

CCDC152 is a protein that is expressed in various tissues throughout the body. It is a key regulator of the cell cycle, which is the process by which cells grow, divide, and replicate their genetic material. CCDC152 is also involved in the development and maintenance of cancer.

Research has shown that CCDC152 plays a key role in the development of many types of cancer, including breast, ovarian, and prostate cancer. It is also involved in the regulation of cell division and has been shown to promote the growth and proliferation of cancer cells.

CCDC152 is a potential drug target for cancer treatment because it is involved in the regulation of cell division and can be targeted with drugs that inhibit its activity. Many studies have shown that inhibiting CCDC152 activity can lead to a reduction in the growth and proliferation of cancer cells.

One of the main challenges in targeting CCDC152 is its widespread distribution in the body. CCDC152 is expressed in many different tissues and organs, including the brain, pancreas, and gastrointestinal tract. This makes it difficult to target the protein directly and to avoid unintended effects.

Another challenge is the complexity of the CCDC152 signaling pathway. CCDC152 is involved in many different signaling pathways and has been shown to interact with many different proteins. This makes it difficult to understand how the protein works and to identify potential targets.

Despite these challenges, research into CCDC152 is ongoing and has shown some promising results. Many studies have shown that inhibiting CCDC152 activity can lead to a reduction in the growth and proliferation of cancer cells. These studies have also shown that targeting CCDC152 with drugs can be effective in treating a variety of cancer types.

In addition to its potential as a drug target, CCDC152 is also a potential biomarker for cancer. Many studies have shown that the expression of CCDC152 is associated with the development and progression of cancer. This makes CCDC152 a promising candidate for use as a biomarker for cancer diagnosis and treatment.

Overall, CCDC152 is a protein that is involved in the regulation of cell division and has been shown to play a key role in the development and maintenance of cancer. As a potential drug target and biomarker, CCDC152 is a promising target for cancer treatment. Further research is needed to fully understand its role and to develop effective treatments.

Protein Name: Coiled-coil Domain Containing 152

The "CCDC152 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CCDC152 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets